Page last updated: 2024-08-24

iobitridol and Hyperlipoproteinemia Type II

iobitridol has been researched along with Hyperlipoproteinemia Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alomar Serrallach, X; Barros Membrilla, A; Cardona Olle, M; Carreras Costa, F; Franco Peral, M; Hidalgo Perez, JA; Leta Petracca, R; Pons-Lladó, G; Pujadas Olano, S; Viladés Medel, D	1

Other Studies

1 other study(ies) available for iobitridol and Hyperlipoproteinemia Type II

Article	Year
Coronary computed tomographic angiographic findings in asymptomatic patients with heterozygous familial hypercholesterolemia and null allele low-density lipoprotein receptor mutations. The American journal of cardiology, 2013, Apr-01, Volume: 111, Issue:7 Topics: Age Factors; Alleles; Case-Control Studies; Chi-Square Distribution; Comorbidity; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Humans; Hyperlipoproteinemia Type II; Iohexol; Lipids; Logistic Models; Male; Middle Aged; Mutation; Phenotype; Prevalence; Receptors, LDL; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Tomography, X-Ray Computed	2013

Article

Year

Coronary computed tomographic angiographic findings in asymptomatic patients with heterozygous familial hypercholesterolemia and null allele low-density lipoprotein receptor mutations.

The American journal of cardiology, 2013, Apr-01, Volume: 111, Issue:7

Topics: Age Factors; Alleles; Case-Control Studies; Chi-Square Distribution; Comorbidity; Contrast Media; Coronary Angiography; Coronary Artery Disease; Female; Humans; Hyperlipoproteinemia Type II; Iohexol; Lipids; Logistic Models; Male; Middle Aged; Mutation; Phenotype; Prevalence; Receptors, LDL; Risk Factors; Severity of Illness Index; Statistics, Nonparametric; Tomography, X-Ray Computed

2013